Comorbidities specific to the cardio-oncology population contribute to the challenges in the interventional management of patients with cancer and cardiovascular disease (CVD). Patients with cancer have generally been excluded from cardiovascular randomized clinical trials. Endovascular procedures may represent a valid option in patients with cancer with a range of CVDs because of their minimally invasive nature. Patients with cancer are less likely to be treated according to societal guidelines because of perceived high risk. This article presents the specific challenges that interventional cardiologists face when caring for patients with cancer and the modern tools to optimize care.
Keywords: Acute coronary syndrome; Cardio-oncology; Coronary artery disease; Interventional oncocardiology; Percutaneous coronary intervention; Transcatheter aortic valve replacement.
Copyright © 2019 Elsevier Inc. All rights reserved.